Orthopedic Alerts for Patients - Implant Recalls

Alerts and implant recalls for patients with orthopedic bone and joint conditions.

An Oklahoma jury awarded $1.2 million to the family of a 96-year-old woman who was abused in a nursing home by two employees. Eryetha Mayberry’s three daughters filed a nursing home abuse lawsuit against Quail Creek Nursing Home and Rehabilitation Center in Oklahoma after hidden camera footage showed the elderly dementia patient’s caretakers manhandling her. The case reached federal court in Oklahoma City and judge announced the verdict on February 13. Daughter Doris Racher and her two sisters installed cameras in their mother’s room after they suspected someone at the home was stealing from her.

Read more ...

The U.S. Food and Drug Administration (FDA) is warning doctors and consumers that a supplement used to treat genetic disorders in children can cause serious harm and in some cases could lead to death. New York-based compounding firm Medisca recently issued a voluntary recall of certain lot numbers of its L-citrulline products and warned consumers [...]

Read more ...

Laura Yaeger has a proven track record when it comes to representing people harmed by dangerous drugs and medical devices. She has represented thousands of individuals and their families against drug and device manufacturers whose products harmed people. She excels at handling mass tort litigation and complex cases. Yaeger is a native Floridian and obtained [...]

Read more ...

Before reaching for a bottle of Tylenol, popping a DayQuil pill or downing a dose of Tylenol Cold and Flu this flu season, Americans should know these popular drugs and their generic counterparts may harm their liver. Acetaminophen effectively lowers fever and relieves minor aches and pains without stomach discomfort and heart issues associated with [...]

Read more ...

Drugmaker Johnson & Johnson is shifting its focus from medical devices and diagnostic equipment to pharmaceuticals, a strategy that will give Merck and Pfizer a good amount of competition this year. Although legal troubles linger regarding the company’s vaginal mesh and faulty joint replacements, J&J witnessed growth in immunology and oncology drug sales in 2013, [...]

Read more ...

FDA officials will again review Pradaxa, one of the best-selling blood thinners on the market that is also linked to accidental, uncontrollable bleeding. The review by the U.S. Food and Drug Administration’s Mini-Sentinel initiative will compare post-trial results between Pradaxa (dabigatran), by drugmaker Boehringer Ingelheim, and its popular counterpart warfarin as a “one-time assessment of [...]

Read more ...

The number of total knee replacement surgeries doubled in the U.S during the last decade, a recent study shows. A 2013 report published in the Journal of Bone and Joint Surgery showed that more Americans are getting knee replacements at younger ages, which could put them at risk for future complications that could require subsequent [...]

Read more ...

The U.S. Food and Drug Administration in early January approved a new pill from Bristol-Meyers Squibb Co. and AstraZeneca to treat Type 2 diabetes after previously rejecting the drug. FDA officials last week announced Farxiga (dapaglifozin) can now be marketed and sold in the U.S. It’s the agency’s first new approval in 2014. The risk [...]

Read more ...

Japanese pharmaceutical company Takeda is dropping plans to develop diabetes drug fasiglifam (TAK-875) because clinical trials showed participants developed dangerous side effects, including possible liver damage. This comes as a blow for the drugmaker as it scrambles to find another drug to take the place of its once best-selling Type 2 diabetes drug Actos. Takeda [...]

Read more ...